- Home
- NBIX vs CX Comparison
NBIX vs CX Comparison
Compare NBIX & CX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- CX
- Stock Information
- Founded
- NBIX 1992
- CX 1906
- Country
- NBIX United States
- CX Mexico
- Employees
- NBIX N/A
- CX N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- CX Building Materials
- Sector
- NBIX Health Care
- CX Industrials
- Exchange
- NBIX Nasdaq
- CX Nasdaq
- Market Cap
- NBIX 12.4B
- CX 10.1B
- IPO Year
- NBIX 1996
- CX 1999
- Fundamental
- Price
- NBIX $134.33
- CX $7.35
- Analyst Decision
- NBIX Strong Buy
- CX Buy
- Analyst Count
- NBIX 21
- CX 5
- Target Price
- NBIX $165.14
- CX $7.45
- AVG Volume (30 Days)
- NBIX 821.3K
- CX 12.0M
- Earning Date
- NBIX 07-30-2025
- CX 07-24-2025
- Dividend Yield
- NBIX N/A
- CX 1.14%
- EPS Growth
- NBIX N/A
- CX 591.00
- EPS
- NBIX 2.96
- CX 0.10
- Revenue
- NBIX $2,412,600,000.00
- CX $15,906,684,000.00
- Revenue This Year
- NBIX $16.29
- CX $3.44
- Revenue Next Year
- NBIX $15.08
- CX $3.26
- P/E Ratio
- NBIX $45.11
- CX $7.89
- Revenue Growth
- NBIX 21.73
- CX N/A
- 52 Week Low
- NBIX $84.23
- CX $4.89
- 52 Week High
- NBIX $157.98
- CX $7.50
- Technical
- Relative Strength Index (RSI)
- NBIX 70.92
- CX 68.62
- Support Level
- NBIX $127.03
- CX $7.12
- Resistance Level
- NBIX $135.94
- CX $7.29
- Average True Range (ATR)
- NBIX 2.85
- CX 0.18
- MACD
- NBIX 0.47
- CX 0.04
- Stochastic Oscillator
- NBIX 87.52
- CX 90.23
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About CX Cemex S.A.B. de C.V. Sponsored ADR
Cemex SAB de CV is a ready-mix concrete company that mainly engaged in activities that are oriented to the construction industry, mainly through the production, marketing, sale, and distribution of cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and also provide related services and reliable construction-related services to customers and communities and maintain business relationships in more than 60 countries throughout the world. The company operates in different parts of the world, with operations in Mexico, the United States, the EMEA region and the SCA&C region.